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It has been shown recently that the alternative pathway of complement activation
can be assembled from six isolated plasma proteins including C3, Factors B and D,
i81H, C3b inactivator, and properdin (1) . The functional activity of this mixture has
been shown to be comparable to that of the alternative pathway in serum with respect
to initiation and amplification. The cytolytic membrane attack pathway is known to
be composed of five plasma proteins, C5, C6, C7, C8, and C9 (2) . Cells capable of
initiating the alternative pathway in serum have been demonstrated to undergo lysis
(3-6) . The question arose, therefore, as to whether the composite mixture of the
isolated alternative pathway proteins and the isolated membrane attack pathway
proteins is capable of causing lysis of cells such as rabbit erythrocytes which activate
the alternative pathway. It is the purpose of this communication to report that the
combination of the 11 isolated proteins in physiological concentrations constitutes on
intact alternative pathway with cytolytic activity quantitatively comparable to that
of serum.
Materials and Methods
BriefDefinitive Report
Purified Components.
￿
C3 (7), Factor B (8), Factor D (9), C3b Inactivator (10), ,81H (10),
native properdin (11), C5 (7), C6 (12), C7 (12), C8 (13), and C9 (14) were prepared as described
elsewhere. The mixture of purified components at physiological concentrations was prepared as
follows : C3 (4,500 jug/ml) was incubated with #1H (1,500 hg/ml) and C3blNA (102 ug/ml) for
30 min at 37° so as to inactivate any C3b contaminant in the C3 preparation. After cooling at
0°C, the remaining eight components were added such that the final protein concentrations
were: 1,200 lug/ml C3; 200 ug/ml Factor B; 2 jug/ml Factor D; 470 jig/ml ,81H; 34 hg/ml
C3blNA; 20 Fug/ml nP; 72,ug/ml C5; 64 l~g/ml C6; 54 Ag/ml C7, 541ug/ml C8, and 58 hg/ml
C9.
Neuraminidase-Treated Sheep Erythrocytes (E.-NA).
￿
E.-NA were prepared as described by
Pangburn and Miiller-Eberhard (5). Sheep erythrocytes suspended in 0.5 M sodium acetate
buffer pH 5.5 containing 0.9% NaCl and 0.1% CaCl2 were incubated for 60 min, at 37°C with
10 U/ml of Vibrio cholerae neuraminidase (Behring Diagnostics, Somerville, N. J.) and then
washed and stored in DGVB.
C4-Depleted Human Serum.
￿
C4-depleted human serum was prepared by immuneadsorption
on columns of Sepharose 4B (Pharmacia Fine Chemicals) to which the IgG fraction of
monospecific goat anti C4 serum had been coupled as described previously (4) .
Buffers.
￿
VB : isotonic veronal buffered saline pH 7.4; Mg-GVB: VB containing 0.1% gelatin
and 1.2 mM MgCl2; DGVB: one-half physiological ionic strength VB containing 0.1% gelatin,
0.15 mM CaCl2, 0.5 MM MgCl2 and 2.5% Dextrose.
Supported by U. S. Public Health Service grants Al 07007 and HL 16411 ; Publication 1620.
$ Recipient of an Established Investigatorship (No. 77 202) from the American Heart Association.
§ Cecil H. and Ida M. Green Investigator in Medical Research, Research Institute of Scripps Clinic.
1722
￿
J. Exp. MED. © The Rockefeller University Press " 0022-1007/78/1201-1722$1 .00
Volume 148
￿
December 1978
￿
1722-1727SCHREIBER AND MULLER-EBERHARD
￿
BRIEF DEFINITIVE REPORT
￿
1723
Sodium Dodecyl Sulfate (SDS)-Polyacrylamide Gel Electrophoresis.
￿
SDS-polyacrylamide gel elec-
trophoresis was performed in 7% polyacrylamide gels using the method of Weber and Osborn
(15) .
Lysis of Erythrocytes by the Alternative Pathway.
￿
This process was performed as described
elsewhere (4) . Total reaction mixtures of 160 dal contained varying amounts of either C4-
depleted serum or purified components, 1 .2 MM MgS04, Mg-GVB, and 107 erythrocytes
suspended in Mg-GVB. After incubation for 10 min at 37°C, lysis was stopped by addition of
1 ml cold Mg-GVB and centrifugation. Hemolysis was determined spectrophotometrically at
412 nm.
Chemotaxis Assayfor Human Polymorphonuclear Leukocytes.
￿
This process was performed using the
Cemotaxis under agarose method ofChenoweth et al. (16) . 1 ED50 U is defined as that amount
of material which elicits one-half of the maximal chemotactic response.
Results
Demonstration of the 11 Isolated Proteins.
￿
Fig. 1 shows the eleven isolated proteins as
they appear after electrophoresis in sodium dodecyl sulfate containing polyacrylamide
gels. All proteins were analyzed at a concentration of - 1 mg/ml. Excluding C3, this
concentration is higher than the concentration of these proteins in serum. In the case
of Factor D, it is 500 times the physiological concentration (17) . All proteins except
C8 appear as single bands under nonreducing conditions. Factors B (18) and D (18),
f1H (19), C6 (12), C7 (12), and C9 (20) are known to be single chain proteins.
Properdin consists of four identical noncovalently bonded polypeptide chains (11, 21) .
C3 (22, 23), C3bINA (10) and C5 (22) are composed of two disulfide-linked noni-
dentical chains. C8 consists of two SDS dissociable subunits, the heavier representing
the disulfide linked a- and -y-chains and the lighter constituting the #-chain (13) .
Inspection of the stained gels indicate 95-99% purity of the isolated proteins.
The Cytolytic Activity of the I1 Isolated Proteins.
￿
The 11 proteins were admixed at
serum concentration: C3, 1,200 ltg/ml; Factor B, 200 lag/ml; Factor D, 2 Ag/ml;
properdin, 20 Ag/ml; C3bINA, 34 ltg/ml; i8lH, 470 Fig/ml; C5, 72 jAg/ml; C6, 64 Fig/
ml; C7, 54 ltg/ml; C8, 54 Etg/ml; and C9 58 Fig/ml. The solvent was veronal-buffered
physiological saline pH 7.4 containing 1 .2 mM MgS04. Cells used were rabbit
erythrocytes (ER), sheep erythrocytes (Es), and neuraminidase-treated sheep erythro-
cytes (Es-NA) . Fig. 2 shows the dose-related lysis of ER and Es-NA but not of Es by
the isolated component mixture. 50% lysis of ER was obtained with 13 .8 ,ul and of Es-
NA with 35.5 hl of the component mixture. No lysis was observed when in control
experiments either the six alternative pathway proteins or the five membrane attack
pathway proteins were omitted, or when individual proteins, such as Factor B, C3, or
C7 were deleted from the complete mixture. In the absence of activating cells, the
component mixture was stable at 37°C with respect to consumption of Factor B, C3,
and C5. Also shown in Fig. 2, is the lytic capacity of C4 depleted human serum. The
dose-response curves are virtually identical to those obtained with the component
mixture, 50% lysis of ER was caused by 13 Etl and of Es-NA by 33 ltl of the serum.
The Nonessential, Regulatory RoleofProperdin in the Lysis ofRabbitErythrocytes.
￿
Previously
reported experiments with properdin-depleted human serum indicated that properdin
enhances rabbit erythrocyte lysis but is not essential (4). We have also shown that
properdin is not essential for the initiation of the alternative pathway assembled from
isolated proteins (1). As shown in Fig. 3, lysis of rabbit erythrocytes by the isolated
component mixture proceeds in absence of properdin. 50% lysis was effected by 37
Htl of mixture without properdin and by 16 lil of mixture with properdin.1724
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FIG. l .
￿
Proteins of the cytolytic alternative pathway. 20-,ug samples ofeach protein were subjected
to SDS-polyacrylamide gel electrophoresis in 7% gels under nonreducing conditions. Gels were
stained with Coomassie Blue dye R250 . Proteins C3 through properdin (P) constitute the compo-
nents of the alternative pathway of activation . Proteins C5 through C9 constitute the components
of the membrane attack pathway .
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FIG. 2 .
￿
Assembly of an intact cytolytic alternative pathway from 11 purified proteins . 160 ttl
reaction mixtures containing 107 erythrocytes, Mg-GVB, and varying amounts of either C4-depleted
serum (") or the mixture of 11 purified components (Q (see Materials and Methods) were incubated
for 10 min at 37°C . Reactions were stopped by addition of 1 ml cold Mg-GVB and centrifugation .
Lysis was determined spectrophotometrically at 412 rim . Shown are the dose-response curves for
lysis of rabbit erythrocytes (-) neuraminidase-treated sheep erythrocytes (-----), and untreated
sheep erythrocytes (- " ---) .
Generation of chemotactic activity in the isolated system.
￿
When the mixture of isolated
components was incubated with 5 mg/ml zymosan for 45 min at 37°C chemotactic
activity for polymorphonuclear leukocytes could subsequently be detected (Table I) .
C4-depleted serum after treatment with zymosan also contained chemotactic activity
but fourfold less than the mixture .SCHREIBER AND MOLLER-EBERHARD
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￿
2,128
C4-depleted human serum
￿
588
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Fic. 3.
￿
The nonessential role of properdin in the alternative pathway. Dose-response curves for
rabbit erythrocyte lysis using the isolated component mixture either containing (O) or lacking (")
native properdin were generated as described in Fig. 2.
TABLE 1
Zymosan-Induced Generation of Chemotactic Activity in the Purified Component
Mixture or in C4-Depleted Human Serum
System
￿
Chemotactic Activity (ED./ml)
+ zymasan
￿
+ Buffer
<100
<100
1725
Discussion
This is the first demonstration of the generation of cytolytic activity of the
alternative pathway assembled entirely from isolated proteins. That the alternative
pathway of complement activation can be assembled from C3, Factors B and D, and
the three known regulatory factors has been documented (1). Whether the interaction
of this activation system with the membrane attack system requires additional factors
had not been critically evaluated heretofore. The results of this study indicate that no
factors other than the 11 isolated proteins are required for the lysis of the alternative
pathway activators: rabbit erythrocytes and neuraminidase-treated sheep erythro-
cytes. The quantitative similarity of the dose-response curves obtained with the
component mixture and with C4-depleted serum further support our conclusion. No
immunoglobulin requirement was found for the two cytolytic systems studied. We do
not wish to imply on the basis of these results, that other cytolytic systems involving
the alternative pathway may not need additional factors. It is known, for instance,
that the cytolytic function of the pathway with regard to measles virus-infected cells
is dependent on IgG with anti-measles virus specificity (24) . And the complement-
dependent lysis of gram-negative bacteria appears to involve lysozyme and perhaps
other factors in addition to the membranolytic complex of complement (25, 26) .
Whether the results of this study have general validity for alternative pathway-
dependent cytolysis necessitates a systematic investigation using the isolated compo-
nent system described here and various cellular activators of the pathway.
Summary
The known cytolytic function of the alternative pathway in serum was quantita-
tively reproduced by combining 11 isolated plasma proteins at their respective serum1726
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concentrations. These proteins are: C3, Factor B, Factor D, C3b inactivator, f31H,
native properdin, C5, C6, C7, C8, and C9. In absence of activators of the alternative
pathway, this mixture was stable at 37°C as evidenced by lack of consumption of
Factor B, C3, and C5 . Upon addition of either rabbit erythrocytes or neuraminidase-
treated sheep erythrocytes, cell lysis ensued and the extent of lysis was dependent on
dose of the component mixture. The dose-response curves obtained with the isolated
component mixture and with C4-depleted serum were virtually indistinguishable.
Nonactivator erythrocytes (untreated sheep erythrocytes) were not lysed by the
component mixture. Deletion of properdin resulted only in a twofold diminution of
the hemolytic activity of the component mixture. No immunoglobulin requirement
was apparent . These results indicate that the cytolytic systems studied are internally
sufficient and capable of coupling the initiation and amplification sequence with the
cytolytic membrane attack sequence.
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